32.85
Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
35.02%
8.857
|
6.56 | 10.88 | 207.83 | - |
| Operating Expenses |
13.94%
131.15
|
115.10 | 105.45 | 99.38 | 88.81 |
| Depreciation and Amortization |
0.00%
0.70
|
0.70 | 0.70 | 0.70 | 0.70 |
| Operating Income/Loss |
12.66%
-122.29
|
-108.54 | -94.57 | 108.45 | -88.81 |
| Nonoperating Income/Loss |
1.66%
9.839
|
10.01 | 11.30 | 10.79 | 11.31 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
14.12%
-112.45
|
-98.54 | -83.27 | 119.24 | -77.49 |
| Basic Average Shares |
3.79%
92.06
|
88.70 | 0.0328 | 88.53 | 88.47 |
| Diluted Average Shares |
3.79%
92.06
|
88.70 | 0.0328 | 89.69 | 88.47 |
| Basic Earnings Per Share |
9.91%
-1.22
|
-1.11 | -0.94 | 1.35 | -0.88 |
| Diluted Earnings Per Share |
9.91%
-1.22
|
-1.11 | -0.94 | 1.33 | -0.88 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):